Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure from Q2 2022 to Q2 2023

Taxonomy & unit: us-gaap: pure
Description: Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
Summary: Elite Pharmaceuticals Inc /Nv/ quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate from Q2 2022 to Q2 2023.
Elite Pharmaceuticals Inc /Nv/ Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending June 30, 2023 was 0.12 pure.

Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2023		0.12	+0.12		Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-14
Q2 2022		0			Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.